Reply: Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation.
Reply: Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation.
复制标题
回复:MicroRNA-126 的尿液排泄是血管瘤增殖的生物标志物。
DOI:
10.1097/prs.0000000000004090
复制
发表时间:
2018
影响因子:
3.6
通讯作者:
Gordillo,GayleM
中科院分区:
文献类型:
--
作者:
Gordillo,GayleM
1. Biswas A, Pan X, Meyer M, et al. Urinary excretion of microRNA-126 is a biomarker for hemangioma proliferation. Plast Reconstr Surg. 2017; 139: 1277e–1284e. 2. Meister J, Schmidt MH. miR-126 and miR-126*: New players in cancer. ScientificWorldJournal 2010; 10: 2090–2100. 3. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010; 107: 810–817. 4. Oglesby IK, Bray IM, Chotirmall SH, et al. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol. 2010; 184: 1702–1709. 5. Mattes J, Collison A, Plank M, Phipps S, Foster PS. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease.